Valeo Pharma's 4Q and fiscal 2022 financials reveal record revenue | News Direct

Valeo Pharma's 4Q and fiscal 2022 financials reveal record revenue

News release by Valeo Pharma Inc.

facebook icon linkedin icon twitter icon pinterest icon email icon Vancouver | February 01, 2023 12:11 PM Eastern Standard Time

Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to share news the company has released its financial results for the fourth quarter and year-ended October 31, 2022.

Saviuk told Proactive the company saw record quarterly revenue of $12.7 million in 4Q 2022, which is up 274% year over year. Valeo also reported record annual revenues of $27.7 million for 2022, compared to $13.6 million in 2021, up 105%.

Saviuk also shared more details about what driven the growth in revenue and what is planned in 2023 to fuel the momentum.

 

 

Contact Details

 

Proactive

 

+1 347-449-0879

 

na-editorial@proactiveinvestors.com

Tags

proactiveinvestorsvaleopharmainctsxvphotcqbvphifpharmainvestinvestinginvestmentinvestorstockmarketstocksstockstockmarketnews